✦ LIBER ✦

Placebo-controlled trials in psychiatric research: an ethical perspective

✍ Scribed by Franklin G Miller

Book ID: 119408217
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 57 KB
Volume: 47
Category: Article
ISSN: 0006-3223
DOI: 10.1016/s0006-3223(00)00833-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Placebos and paradoxes in psychiatric re

Placebos and paradoxes in psychiatric research: an ethics perspective

✍ Laura Weiss Roberts; John Lauriello; Cynthia Geppert; Samuel J Keith 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Placebo-controlled trials in pediatric u

Placebo-controlled trials in pediatric urology: A cautionary view from an ethical perspective

✍ Luis H.P. Braga; Darius J. Bagli; Armando J. Lorenzo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Placebo-controlled clinical trials in mu

Placebo-controlled clinical trials in multiple sclerosis: Ethical considerations

✍ Fred D. Lublin; Stephen C. Reingold 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

Ethics of placebo-controlled trials in d

Ethics of placebo-controlled trials in depression

✍ J. Guy Edwards 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

## Ethics of placebo-controlled trials in depression Some believe that introducing a placebo control into an antidepressant drug trial means that ill patients are being unnecessarily deprived of treatment. As a result, many clinicians and ethical committees are opposed to the use of such trial met

Is It Ethical to Conduct Placebo-Control

Is It Ethical to Conduct Placebo-Controlled Clinical Trials in the Development of New Agents for Osteoporosis? An Industry Perspective

✍ Michael Rosenblatt 📂 Article 📅 2003 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 32 KB

Placebo controlled treatment trials in h

Placebo controlled treatment trials in hepatic encephalopathy are feasible and ethical

✍ Ravi K. Ghanta; Kevin D. Mullen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Background & aims: Hepatic encephalopathy in cirrhosis is contributed to by toxic products deriving from the proteolytic bacterial flora-related degradation of dietary nitrogen substances. Acarbose is a novel hypoglycemic agent acting through the inhibition of glucose absorption in the gut and the p